Cytomegalovirus is one of the most important infections to occur after allogeneic
haematopoietic stem cell transplantation (HSCT), and an increasing number of reports …

Cytomegalovirus (CMV) reactivation remains one of the most common and life-threatening
infectious complications following allogeneic hematopoietic stem cell transplantation …

Background Cytomegalovirus (CMV) infection remains a common complication after
allogeneic hematopoietic-cell transplantation. Letermovir is an antiviral drug that inhibits the …

Prior studies suggest increased cytomegalovirus (CMV) infection after haploidentical donor
transplantation with posttransplant cyclophosphamide (HaploCy). The role of allograft …

Background Although cytomegalovirus viral load is commonly used to guide pre-emptive
therapy in the post-transplantation setting, few data are available correlating viraemia with …

Cytomegalovirus (CMV) infection is a common complication of allogeneic hematopoietic cell
transplantation (HCT). In this trial, we randomized adult CMV-seropositive HCT recipients …

Abstract The Practice Guidelines Committee of the American Society for Transplantation and
Cellular Therapy partnered with its Transplant Infectious Disease Special Interest Group to …

Background The use of available antiviral agents for the prevention of cytomegalovirus
(CMV) disease is limited by frequent toxic effects and the emergence of resistance. CMX001 …

BACKGROUND. Graft-versus-host disease (GVHD) is a major cause of morbidity and
mortality following allogeneic hematopoietic stem cell transplantation (HCT). In mice, naive T …

The association between cytomegalovirus (CMV) reactivation and relapse was evaluated in
a large cohort of patients with acute myeloid leukemia (AML)(n= 761), acute lymphoblastic …